Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP: medical device reports filed with FDA

21,146 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

21,146
device reports naming the brand
0.1% of all MAUDE reports · about 3,059 a year
3,530
reports, 12 months to August 2026
3,707 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

21,146 medical device reports received by FDA name the brand "BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

3,530 reports arrived in the 12 months to August 2026, close to the 3,707 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.7%), loss of osseointegration (16.9%) and fracture (1.3%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0431862Sep 2021: 189Oct 2021: 235Nov 2021: 200Dec 2021: 1802022Jan 2022: 285Feb 2022: 169Mar 2022: 244Apr 2022: 209May 2022: 213Jun 2022: 225Jul 2022: 218Aug 2022: 219Sep 2022: 193Oct 2022: 272Nov 2022: 293Dec 2022: 2552023Jan 2023: 212Feb 2023: 242Mar 2023: 241Apr 2023: 267May 2023: 307Jun 2023: 356Jul 2023: 339Aug 2023: 306Sep 2023: 277Oct 2023: 294Nov 2023: 310Dec 2023: 3012024Jan 2024: 298Feb 2024: 312Mar 2024: 260Apr 2024: 345May 2024: 353Jun 2024: 287Jul 2024: 281Aug 2024: 257Sep 2024: 352Oct 2024: 312Nov 2024: 349Dec 2024: 2862025Jan 2025: 249Feb 2025: 282Mar 2025: 298Apr 2025: 154May 2025: 0Jun 2025: 862Jul 2025: 264Aug 2025: 299Sep 2025: 386Oct 2025: 304Nov 2025: 260Dec 2025: 3282026Jan 2026: 269Feb 2026: 237Mar 2026: 288Apr 2026: 286May 2026: 306Jun 2026: 266Jul 2026: 264Aug 2026: 336

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,8463,6922019: 1,27920192020: 1,67920202021: 2,31120212022: 2,79520222023: 3,45220232024: 3,69220242025: 3,68620252026: 2,2522026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%21,146
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report81.2%17,161
Voluntary report0%0
User facility report0%0
Distributor report18.8%3,985
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate16,00975.7%62.8%
Loss of osseointegration3,56516.9%22.4%
Fracturea broken bone2791.3%1.6%
Difficult to insertthe device was hard to insert1530.7%0.4%
Separation failure200.1%0.1%
Difficult to removethe device was hard to remove100%0%
Unstable100%0%
Unintended movement90%0%
Therapeutic or diagnostic output failure50%0%
Activation, positioning or separation problem40%0%
Defective devicethe device was defective30%0%
Positioning problem20%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis6,19429.3%
Painpain, site not specified4,01219%
Tissue damage1,7558.3%
Inflammationinflammation1,6868%
Swelling/ edema1,1085.2%
Hemorrhage/blood loss/bleeding9764.6%
Fistula7963.8%
Abscessa collection of pus7213.4%
Hyperresponsive to stimuli5522.6%
Hypersensitivity/allergic reaction2201%
Failure of implant1520.7%
Swellingswelling1460.7%
Inadequate osseointegration590.3%
Numbnessnumbness520.2%
Increased sensitivity370.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLActive? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports21,1463,924,24126,136,888
Share of that pool—0.5%0.1%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer81.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP reports

How many FDA reports name BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP?

21,146 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 3,530 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.7%), loss of osseointegration (16.9%), fracture (1.3%), difficult to insert (0.7%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (81.2%) and distributor reports (18.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.